Several studies suggest that MEKK2 can contribute to the growth and migration of cancer cells by modulating the EMT process in multiple tumour diseases, including lung cancer, breast cancer and gastric cancer.16, 17, 25. Here, MAP3K2 is linked to lung carcinoma.